Kabushiki Kaisha Yakult Honsha

Fumiyasu Ishikawa

Yasuhisa Shimakawa

Tohru Iino

Hiroko Hayakawa

Satoshi Matsubara

Ryoichi Akahoshi

Hirokazu Tsuji

Koichi Yoshimura

Susumu Mizusawa

Masaki Serata

Takashi Morishita

Mika Miura

Norie Masuoka

Harue Sone

Mitsuyoshi Kano

Daisuke Nozaki

Koichiro Sonoike

Eiji Hayashida

Akimitsu Takagi

Atsushi Nose

Disclosed is a novel lactic acid bacterium belonging to, which has an excellent fermentative ability affording high achievable cell counts even if various vegetable or fruit juices are used as fermentative substrates. The lactic acid bacterium belonging tois characterized by the achievable viable cell counts being 10CFU/ml or more in both cases when 100% juice of grape or of orange is used as fermentative substrate.

[object Object]

It is intended to providewhich has an effect of killingand shows high survivability even in the case of being stored in a fermented milk food or drink under aerobic condition. Thehas the following characteristics: (1) having an effect of killing; and (2) showing a survival rate of 10% or higher in the case of being stored in a fermented milk drink or food under aerobic condition at 10&#xb0; C. for 14 days.

To provide a bacterium belonging to the genuswhich is excellent in a survival ability in the gastrointestinal tract, has an effect of inhibiting the cholesterol absorption in the intestinal tract, and is excellent in lipid metabolism ameliorating effects including decreasing the blood cholesterol level and the like, and shows a high survival rate after storage, and a cholesterol absorption inhibitor using the same. The invention provides a cholesterol absorption inhibitor containing, as an active ingredient, at least one microorganism selected fromsubsp.YIT 10394,subsp.JCM 1253,subsp.JCM 7117, andsubsp.

Cholesterol absorption inhibitor

A bone metabolism improving agent characterized by containing as the active ingredient fermented soybean milk which is obtained by fermenting soybean milk with a lactic acid bacterium or a bifidobacterium. The bone metabolism improving agent is efficacious in treating and preventing diseases in association with lowered bone metabolism such as osteoporosis and, at the same time, satisfies requirements in cost and smooth intake.

Bone metabolism improving agent

Athat is resistant to acid and bile and which retains at least 20% viability after acid and bile treatment. Foods and drinks containing an acid- and bile-resistant. Methods for providing viableto the intestine after ingestion of a food or drink containing an acid- and bile-resistant

Method of evaluating the extent of reaching the intestine of bifidobacterium in fermented milk food or drink

A strain provided is showing a viable count of 1&times;10 cells/ml or more immediately after culturing in a soymilk medium and sustaining a viable count of 1&times;10 cells/ml or more after storage at 10&deg; C. for 14 days. The strain is preferably FERM BP-6223, and is used for producing fermented soymilk.

Bifidobacterium breve ferm BP 6223 for producing fermented soymilk

Growing community of inventors

Tokyo, Japan

Fumiyasu Ishikawa